Global and United States Factor VIII Deficiency Treatment Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 27-Oct-2020
No. of pages: 126
Inquire Before Buying

Global Factor VIII Deficiency Treatment Scope and Market Size

Factor VIII Deficiency Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Factor VIII Deficiency Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into

- Hemophilia A Drugs

- Hemophilia A Inhibitors Treatment

- Von Willebrand Disease Treatment

Market segment by Application, split into

- Hospitals

- Clinics

- Other

Based on regional and country-level analysis, the Factor VIII Deficiency Treatment market has been segmented as follows:

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Factor VIII Deficiency Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

The key players covered in this study

- Pfizer

- Takeda

- Bayer HealthCare

- CSL

- Grifols

- Novo Nordisk

- F. Hoffmann-La Roche

- Kedrion

- Octapharma

- Biogen Idec

- BioMarin Pharmaceutical

- Sangamo Therapeutics

- Spark Therapeutics

- Swedish Orphan Biovitrum

- Uniqure NV

- Amarna Therapeutics

- Dimension Therapeutics

Global and United States Factor VIII Deficiency Treatment Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Factor VIII Deficiency Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Hemophilia A Drugs
1.2.3 Hemophilia A Inhibitors Treatment
1.2.4 Von Willebrand Disease Treatment
1.3 Market by Application
1.3.1 Global Factor VIII Deficiency Treatment Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Factor VIII Deficiency Treatment Market Perspective (2015-2026)
2.2 Global Factor VIII Deficiency Treatment Growth Trends by Regions
2.2.1 Factor VIII Deficiency Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Factor VIII Deficiency Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Factor VIII Deficiency Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Factor VIII Deficiency Treatment Players by Market Size
3.1.1 Global Top Factor VIII Deficiency Treatment Players by Revenue (2015-2020)
3.1.2 Global Factor VIII Deficiency Treatment Revenue Market Share by Players (2015-2020)
3.2 Global Factor VIII Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Factor VIII Deficiency Treatment Revenue
3.4 Global Factor VIII Deficiency Treatment Market Concentration Ratio
3.4.1 Global Factor VIII Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Factor VIII Deficiency Treatment Revenue in 2019
3.5 Key Players Factor VIII Deficiency Treatment Area Served
3.6 Key Players Factor VIII Deficiency Treatment Product Solution and Service
3.7 Date of Enter into Factor VIII Deficiency Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Factor VIII Deficiency Treatment Breakdown Data by Type (2015-2026)
4.1 Global Factor VIII Deficiency Treatment Historic Market Size by Type (2015-2020)
4.2 Global Factor VIII Deficiency Treatment Forecasted Market Size by Type (2021-2026)
5 Factor VIII Deficiency Treatment Breakdown Data by Application (2015-2026)
5.1 Global Factor VIII Deficiency Treatment Historic Market Size by Application (2015-2020)
5.2 Global Factor VIII Deficiency Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Factor VIII Deficiency Treatment Market Size (2015-2026)
6.2 North America Factor VIII Deficiency Treatment Market Size by Type (2015-2020)
6.3 North America Factor VIII Deficiency Treatment Market Size by Application (2015-2020)
6.4 North America Factor VIII Deficiency Treatment Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Factor VIII Deficiency Treatment Market Size (2015-2026)
7.2 Europe Factor VIII Deficiency Treatment Market Size by Type (2015-2020)
7.3 Europe Factor VIII Deficiency Treatment Market Size by Application (2015-2020)
7.4 Europe Factor VIII Deficiency Treatment Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Factor VIII Deficiency Treatment Market Size (2015-2026)
8.2 China Factor VIII Deficiency Treatment Market Size by Type (2015-2020)
8.3 China Factor VIII Deficiency Treatment Market Size by Application (2015-2020)
8.4 China Factor VIII Deficiency Treatment Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Factor VIII Deficiency Treatment Market Size (2015-2026)
9.2 Japan Factor VIII Deficiency Treatment Market Size by Type (2015-2020)
9.3 Japan Factor VIII Deficiency Treatment Market Size by Application (2015-2020)
9.4 Japan Factor VIII Deficiency Treatment Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Factor VIII Deficiency Treatment Market Size (2015-2026)
10.2 Southeast Asia Factor VIII Deficiency Treatment Market Size by Type (2015-2020)
10.3 Southeast Asia Factor VIII Deficiency Treatment Market Size by Application (2015-2020)
10.4 Southeast Asia Factor VIII Deficiency Treatment Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Factor VIII Deficiency Treatment Introduction
11.1.4 Pfizer Revenue in Factor VIII Deficiency Treatment Business (2015-2020))
11.1.5 Pfizer Recent Development
11.2 Takeda
11.2.1 Takeda Company Details
11.2.2 Takeda Business Overview
11.2.3 Takeda Factor VIII Deficiency Treatment Introduction
11.2.4 Takeda Revenue in Factor VIII Deficiency Treatment Business (2015-2020)
11.2.5 Takeda Recent Development
11.3 Bayer HealthCare
11.3.1 Bayer HealthCare Company Details
11.3.2 Bayer HealthCare Business Overview
11.3.3 Bayer HealthCare Factor VIII Deficiency Treatment Introduction
11.3.4 Bayer HealthCare Revenue in Factor VIII Deficiency Treatment Business (2015-2020)
11.3.5 Bayer HealthCare Recent Development
11.4 CSL
11.4.1 CSL Company Details
11.4.2 CSL Business Overview
11.4.3 CSL Factor VIII Deficiency Treatment Introduction
11.4.4 CSL Revenue in Factor VIII Deficiency Treatment Business (2015-2020)
11.4.5 CSL Recent Development
11.5 Grifols
11.5.1 Grifols Company Details
11.5.2 Grifols Business Overview
11.5.3 Grifols Factor VIII Deficiency Treatment Introduction
11.5.4 Grifols Revenue in Factor VIII Deficiency Treatment Business (2015-2020)
11.5.5 Grifols Recent Development
11.6 Novo Nordisk
11.6.1 Novo Nordisk Company Details
11.6.2 Novo Nordisk Business Overview
11.6.3 Novo Nordisk Factor VIII Deficiency Treatment Introduction
11.6.4 Novo Nordisk Revenue in Factor VIII Deficiency Treatment Business (2015-2020)
11.6.5 Novo Nordisk Recent Development
11.7 F. Hoffmann-La Roche
11.7.1 F. Hoffmann-La Roche Company Details
11.7.2 F. Hoffmann-La Roche Business Overview
11.7.3 F. Hoffmann-La Roche Factor VIII Deficiency Treatment Introduction
11.7.4 F. Hoffmann-La Roche Revenue in Factor VIII Deficiency Treatment Business (2015-2020)
11.7.5 F. Hoffmann-La Roche Recent Development
11.8 Kedrion
11.8.1 Kedrion Company Details
11.8.2 Kedrion Business Overview
11.8.3 Kedrion Factor VIII Deficiency Treatment Introduction
11.8.4 Kedrion Revenue in Factor VIII Deficiency Treatment Business (2015-2020)
11.8.5 Kedrion Recent Development
11.9 Octapharma
11.9.1 Octapharma Company Details
11.9.2 Octapharma Business Overview
11.9.3 Octapharma Factor VIII Deficiency Treatment Introduction
11.9.4 Octapharma Revenue in Factor VIII Deficiency Treatment Business (2015-2020)
11.9.5 Octapharma Recent Development
11.10 Biogen Idec
11.10.1 Biogen Idec Company Details
11.10.2 Biogen Idec Business Overview
11.10.3 Biogen Idec Factor VIII Deficiency Treatment Introduction
11.10.4 Biogen Idec Revenue in Factor VIII Deficiency Treatment Business (2015-2020)
11.10.5 Biogen Idec Recent Development
11.11 BioMarin Pharmaceutical
10.11.1 BioMarin Pharmaceutical Company Details
10.11.2 BioMarin Pharmaceutical Business Overview
10.11.3 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Introduction
10.11.4 BioMarin Pharmaceutical Revenue in Factor VIII Deficiency Treatment Business (2015-2020)
10.11.5 BioMarin Pharmaceutical Recent Development
11.12 Sangamo Therapeutics
10.12.1 Sangamo Therapeutics Company Details
10.12.2 Sangamo Therapeutics Business Overview
10.12.3 Sangamo Therapeutics Factor VIII Deficiency Treatment Introduction
10.12.4 Sangamo Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2015-2020)
10.12.5 Sangamo Therapeutics Recent Development
11.13 Spark Therapeutics
10.13.1 Spark Therapeutics Company Details
10.13.2 Spark Therapeutics Business Overview
10.13.3 Spark Therapeutics Factor VIII Deficiency Treatment Introduction
10.13.4 Spark Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2015-2020)
10.13.5 Spark Therapeutics Recent Development
11.14 Swedish Orphan Biovitrum
10.14.1 Swedish Orphan Biovitrum Company Details
10.14.2 Swedish Orphan Biovitrum Business Overview
10.14.3 Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Introduction
10.14.4 Swedish Orphan Biovitrum Revenue in Factor VIII Deficiency Treatment Business (2015-2020)
10.14.5 Swedish Orphan Biovitrum Recent Development
11.15 Uniqure NV
10.15.1 Uniqure NV Company Details
10.15.2 Uniqure NV Business Overview
10.15.3 Uniqure NV Factor VIII Deficiency Treatment Introduction
10.15.4 Uniqure NV Revenue in Factor VIII Deficiency Treatment Business (2015-2020)
10.15.5 Uniqure NV Recent Development
11.16 Amarna Therapeutics
10.16.1 Amarna Therapeutics Company Details
10.16.2 Amarna Therapeutics Business Overview
10.16.3 Amarna Therapeutics Factor VIII Deficiency Treatment Introduction
10.16.4 Amarna Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2015-2020)
10.16.5 Amarna Therapeutics Recent Development
11.17 Dimension Therapeutics
10.17.1 Dimension Therapeutics Company Details
10.17.2 Dimension Therapeutics Business Overview
10.17.3 Dimension Therapeutics Factor VIII Deficiency Treatment Introduction
10.17.4 Dimension Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2015-2020)
10.17.5 Dimension Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Factor VIII Deficiency Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Hemophilia A Drugs
Table 4. Key Players of Hemophilia A Inhibitors Treatment
Table 5. Key Players of Von Willebrand Disease Treatment
Table 6. Global Factor VIII Deficiency Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Factor VIII Deficiency Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Factor VIII Deficiency Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Factor VIII Deficiency Treatment Market Share by Regions (2015-2020)
Table 10. Global Factor VIII Deficiency Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Factor VIII Deficiency Treatment Market Share by Regions (2021-2026)
Table 12. Factor VIII Deficiency Treatment Market Market Trends
Table 13. Factor VIII Deficiency Treatment Market Drivers
Table 14. Factor VIII Deficiency Treatment Market Challenges
Table 15. Factor VIII Deficiency Treatment Market Restraints
Table 16. Global Factor VIII Deficiency Treatment Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Factor VIII Deficiency Treatment Market Share by Players (2015-2020)
Table 18. Global Top Factor VIII Deficiency Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Factor VIII Deficiency Treatment as of 2019)
Table 19. Global Factor VIII Deficiency Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Factor VIII Deficiency Treatment Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Factor VIII Deficiency Treatment Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Factor VIII Deficiency Treatment Market Size Share by Type (2015-2020)
Table 25. Global Factor VIII Deficiency Treatment Revenue Market Share by Type (2021-2026)
Table 26. Global Factor VIII Deficiency Treatment Market Size Share by Application (2015-2020)
Table 27. Global Factor VIII Deficiency Treatment Market Size by Application (2015-2020) (US$ Million)
Table 28. Global Factor VIII Deficiency Treatment Market Size Share by Application (2021-2026)
Table 29. North America Factor VIII Deficiency Treatment Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Factor VIII Deficiency Treatment Market Share by Type (2015-2020)
Table 31. North America Factor VIII Deficiency Treatment Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Factor VIII Deficiency Treatment Market Share by Application (2015-2020)
Table 33. North America Factor VIII Deficiency Treatment Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Factor VIII Deficiency Treatment Market Share by Country (2015-2020)
Table 35. Europe Factor VIII Deficiency Treatment Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Factor VIII Deficiency Treatment Market Share by Type (2015-2020)
Table 37. Europe Factor VIII Deficiency Treatment Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Factor VIII Deficiency Treatment Market Share by Application (2015-2020)
Table 39. Europe Factor VIII Deficiency Treatment Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Factor VIII Deficiency Treatment Market Share by Country (2015-2020)
Table 41. China Factor VIII Deficiency Treatment Market Size by Type (2015-2020) (US$ Million)
Table 42. China Factor VIII Deficiency Treatment Market Share by Type (2015-2020)
Table 43. China Factor VIII Deficiency Treatment Market Size by Application (2015-2020) (US$ Million)
Table 44. China Factor VIII Deficiency Treatment Market Share by Application (2015-2020)
Table 45. China Factor VIII Deficiency Treatment Market Size by Region (US$ Million) (2015-2020)
Table 46. China Factor VIII Deficiency Treatment Market Share by Region (2015-2020)
Table 47. Japan Factor VIII Deficiency Treatment Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan Factor VIII Deficiency Treatment Market Share by Type (2015-2020)
Table 49. Japan Factor VIII Deficiency Treatment Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan Factor VIII Deficiency Treatment Market Share by Application (2015-2020)
Table 51. Japan Factor VIII Deficiency Treatment Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan Factor VIII Deficiency Treatment Market Share by Country (2015-2020)
Table 53. Southeast Asia Factor VIII Deficiency Treatment Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia Factor VIII Deficiency Treatment Market Share by Type (2015-2020)
Table 55. Southeast Asia Factor VIII Deficiency Treatment Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia Factor VIII Deficiency Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Factor VIII Deficiency Treatment Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia Factor VIII Deficiency Treatment Market Share by Country (2015-2020)
Table 59. Pfizer Company Details
Table 60. Pfizer Business Overview
Table 61. Pfizer Product
Table 62. Pfizer Revenue in Factor VIII Deficiency Treatment Business (2015-2020) (US$ Million)
Table 63. Pfizer Recent Development
Table 64. Takeda Company Details
Table 65. Takeda Business Overview
Table 66. Takeda Product
Table 67. Takeda Revenue in Factor VIII Deficiency Treatment Business (2015-2020) (US$ Million)
Table 68. Takeda Recent Development
Table 69. Bayer HealthCare Company Details
Table 70. Bayer HealthCare Business Overview
Table 71. Bayer HealthCare Product
Table 72. Bayer HealthCare Revenue in Factor VIII Deficiency Treatment Business (2015-2020) (US$ Million)
Table 73. Bayer HealthCare Recent Development
Table 74. CSL Company Details
Table 75. CSL Business Overview
Table 76. CSL Product
Table 77. CSL Revenue in Factor VIII Deficiency Treatment Business (2015-2020) (US$ Million)
Table 78. CSL Recent Development
Table 79. Grifols Company Details
Table 80. Grifols Business Overview
Table 81. Grifols Product
Table 82. Grifols Revenue in Factor VIII Deficiency Treatment Business (2015-2020) (US$ Million)
Table 83. Grifols Recent Development
Table 84. Novo Nordisk Company Details
Table 85. Novo Nordisk Business Overview
Table 86. Novo Nordisk Product
Table 87. Novo Nordisk Revenue in Factor VIII Deficiency Treatment Business (2015-2020) (US$ Million)
Table 88. Novo Nordisk Recent Development
Table 89. F. Hoffmann-La Roche Company Details
Table 90. F. Hoffmann-La Roche Business Overview
Table 91. F. Hoffmann-La Roche Product
Table 92. F. Hoffmann-La Roche Revenue in Factor VIII Deficiency Treatment Business (2015-2020) (US$ Million)
Table 93. F. Hoffmann-La Roche Recent Development
Table 94. Kedrion Business Overview
Table 95. Kedrion Product
Table 96. Kedrion Company Details
Table 97. Kedrion Revenue in Factor VIII Deficiency Treatment Business (2015-2020) (US$ Million)
Table 98. Kedrion Recent Development
Table 99. Octapharma Company Details
Table 100. Octapharma Business Overview
Table 101. Octapharma Product
Table 102. Octapharma Revenue in Factor VIII Deficiency Treatment Business (2015-2020) (US$ Million)
Table 103. Octapharma Recent Development
Table 104. Biogen Idec Company Details
Table 105. Biogen Idec Business Overview
Table 106. Biogen Idec Product
Table 107. Biogen Idec Revenue in Factor VIII Deficiency Treatment Business (2015-2020) (US$ Million)
Table 108. Biogen Idec Recent Development
Table 109. BioMarin Pharmaceutical Company Details
Table 110. BioMarin Pharmaceutical Business Overview
Table 111. BioMarin Pharmaceutical Product
Table 112. BioMarin Pharmaceutical Revenue in Factor VIII Deficiency Treatment Business (2015-2020) (US$ Million)
Table 113. BioMarin Pharmaceutical Recent Development
Table 114. Sangamo Therapeutics Company Details
Table 115. Sangamo Therapeutics Business Overview
Table 116. Sangamo Therapeutics Product
Table 117. Sangamo Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2015-2020) (US$ Million)
Table 118. Sangamo Therapeutics Recent Development
Table 119. Spark Therapeutics Company Details
Table 120. Spark Therapeutics Business Overview
Table 121. Spark Therapeutics Product
Table 122. Spark Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2015-2020) (US$ Million)
Table 123. Spark Therapeutics Recent Development
Table 124. Swedish Orphan Biovitrum Company Details
Table 125. Swedish Orphan Biovitrum Business Overview
Table 126. Swedish Orphan Biovitrum Product
Table 127. Swedish Orphan Biovitrum Revenue in Factor VIII Deficiency Treatment Business (2015-2020) (US$ Million)
Table 128. Swedish Orphan Biovitrum Recent Development
Table 129. Uniqure NV Company Details
Table 130. Uniqure NV Business Overview
Table 131. Uniqure NV Product
Table 132. Uniqure NV Revenue in Factor VIII Deficiency Treatment Business (2015-2020) (US$ Million)
Table 133. Uniqure NV Recent Development
Table 134. Amarna Therapeutics Company Details
Table 135. Amarna Therapeutics Business Overview
Table 136. Amarna Therapeutics Product
Table 137. Amarna Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2015-2020) (US$ Million)
Table 138. Amarna Therapeutics Recent Development
Table 139. Dimension Therapeutics Company Details
Table 140. Dimension Therapeutics Business Overview
Table 141. Dimension Therapeutics Product
Table 142. Dimension Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2015-2020) (US$ Million)
Table 143. Dimension Therapeutics Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Factor VIII Deficiency Treatment Market Share by Type: 2020 VS 2026
Figure 2. Hemophilia A Drugs Features
Figure 3. Hemophilia A Inhibitors Treatment Features
Figure 4. Von Willebrand Disease Treatment Features
Figure 5. Global Factor VIII Deficiency Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. Factor VIII Deficiency Treatment Report Years Considered
Figure 10. Global Factor VIII Deficiency Treatment Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global Factor VIII Deficiency Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Factor VIII Deficiency Treatment Market Share by Regions (2021-2026)
Figure 13. Global Factor VIII Deficiency Treatment Market Share by Players in 2019
Figure 14. Global Top Factor VIII Deficiency Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Factor VIII Deficiency Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Factor VIII Deficiency Treatment Revenue in 2019
Figure 16. North America Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Rest of Europe Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa Factor VIII Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Pfizer Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2015-2020)
Figure 44. Takeda Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2015-2020)
Figure 45. Bayer HealthCare Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2015-2020)
Figure 46. CSL Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2015-2020)
Figure 47. Grifols Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2015-2020)
Figure 48. Novo Nordisk Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2015-2020)
Figure 49. F. Hoffmann-La Roche Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2015-2020)
Figure 50. Kedrion Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2015-2020)
Figure 51. Octapharma Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2015-2020)
Figure 52. Biogen Idec Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2015-2020)
Figure 53. BioMarin Pharmaceutical Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2015-2020)
Figure 54. Sangamo Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2015-2020)
Figure 55. Spark Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2015-2020)
Figure 56. Swedish Orphan Biovitrum Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2015-2020)
Figure 57. Uniqure NV Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2015-2020)
Figure 58. Amarna Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2015-2020)
Figure 59. Dimension Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2015-2020)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
  • (Post-pandemic Era) - Global Thrombin Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
    Published: 27-Nov-2020        Price: US 3650 Onwards        Pages: 101
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • (Post-pandemic Era) - Global Thrombin Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type
    Published: 27-Nov-2020        Price: US 4860 Onwards        Pages: 83
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Thrombin growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related regions ......
  • (Post-pandemic Era) - Global Thrombin Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 27-Nov-2020        Price: US 3620 Onwards        Pages: 104
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • Global and China Hemophilia Treatment Market Size, Status and Forecast 2020-2026
    Published: 24-Nov-2020        Price: US 3900 Onwards        Pages: 91
    Global Hemophilia Treatment Scope and Market Size Hemophilia Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hemophilia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Market segment by Type, the product can be spl......
  • Asia Pacific Anticoagulants Market Forecast 2021-2028
    Published: 24-Nov-2020        Price: US 1250 Onwards        Pages: 159
    KEY FINDINGS The Asia Pacific anticoagulants market is anticipated to record a CAGR of 8.83%, over the forecast years of 2021 to 2028. Factors such as, the increasing research and development endeavors for developing newer therapeutics, the lucrative opportunities across emerging economies, the high prevalence of COPD, and the developing healthcare infrastructure, are accredited to the region's market growth. MARKET INSIGHTS The Asia Pacific anticoagulants market gro......
  • Europe Anticoagulants Market Forecast 2021-2028
    Published: 24-Nov-2020        Price: US 1250 Onwards        Pages: 155
    KEY FINDINGS The Europe anticoagulants market is expected to record a CAGR of 8.48%, over the forecast period of 2021 to 2028. The region's market growth is accredited to the rise in healthcare expenditure, the growing prevalence of venous thromboembolism (VTE) and atrial fibrillation, the increase in the geriatric and obese population, and the surging adoption of NOACs. MARKET INSIGHTS The Europe anticoagulants market growth is analyzed by assessing the United Kingd......
  • North America Anticoagulants Market Forecast 2021-2028
    Published: 24-Nov-2020        Price: US 1250 Onwards        Pages: 163
    KEY FINDINGS The North America anticoagulants market is anticipated to record a CAGR of 8.16%, over the forecast period of 2021 to 2028. The region's key market growth drivers include the strong presence of hospitals and diagnostic centers, the easy availability of treatments, and increased awareness concerning novel therapeutics. MARKET INSIGHTS The North America anticoagulants market growth is assessed by analyzing Canada and the United States. Canada's market is w......
  • India Anticoagulants Market Forecast 2021-2025
    Published: 24-Nov-2020        Price: US 700 Onwards        Pages: 109
    KEY FINDINGS The India anticoagulants market is anticipated to record a CAGR of 9.72%, during the forecast period. The country's key market growth propellers include the introduction of newer oral anticoagulants (NOACs), the growing prevalence of cardiovascular diseases (CVDs), and the increased incidence of chronic obstructive pulmonary disease (COPD). The base year considered for the market study is 2020, while the forecast period is from 2021 to 2025. MARKET INSIGHTS......
  • Global Anticoagulants Market Forecast 2021-2028
    Published: 24-Nov-2020        Price: US 2500 Onwards        Pages: 210
    KEY FINDINGS The global anticoagulants market is estimated to project a CAGR of 8.42% during the forecast period of 2021 to 2028. The key market growth drivers include, the surging approval of novel oral anticoagulants (NOAC), technical advancements, and the surging incidence of chronic diseases. MARKET INSIGHTS Anticoagulants or blood thinners, entail chemical substances that minimize or prevent blood coagulation, thereby prolonging the clotting period. Typically, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs